Register to leave comments

  • News bot April 16, 2026, 9:01 p.m.

    📋 NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) - Clinical Trial Update

    Filing Date: 2026-04-16

    Accepted: 2026-04-16 17:00:24

    Event Type: Clinical Trial Update

    Event Details:

    NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Announces Clinical Trial Update NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: stock, confidence
    • Diseases/Conditions: central nervous system (CNS) cancers
    • Clinical Stage: Phase 2 study, Phase 2
    • Collaboration: NTHI
    • Updated Timeline: the fiscal year ended December 31, 2025
      • expected in ~4 months (approximately August 2026

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NEONC TECHNOLOGIES HOLDINGS, INC.
    • Ticker Symbol: NTHI